安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- Engineering Proteins that Power Progress | Dyadic
Dyadic provides high-performance enzymes and proteins that enhance efficiency across biofuels, textiles, and specialty chemicals Our proven platforms enable faster, flexible, sustainable, and affordable bioprocessing
- About Us - Dyadic
Dyadic works side-by-side with customers to co-develop, customize, and scale proteins that fit their exact needs Our approach reduces time to market, lowers cost, and minimizes supply-chain risk, making innovation commercially viable
- Dyadic International, Inc. Announces Strategic Rebrand to Dyadic . . .
Dyadic Applied BioSolutions is a global biotechnology company focused on the scalable production of high-value, precision engineered input proteins for non-therapeutic applications across the life sciences, food and nutrition, and industrial biotechnology sectors
- Dyadic Announces Leadership Change as Part of Ongoing Strategic Shift . . .
Dyadic is focusing on leveraging its microbial platform technologies for itself and its collaborators in a wide range of applications, including life sciences, food, nutrition, wellness, and internal biological products with a secondary focus on human and animal vaccines and therapeutics
- Dyadic Announces Strategic Partnership Agreement to Develop Affordable . . .
Dyadic’s gene expression and protein production platforms are based on the highly productive and scalable fungus Thermothelomyces heterothallica (formerly Myceliophthora thermophila)
- Dyadic Announces Third Quarter 2025 Financial Results and Highlights . . .
“During the third quarter, Dyadic completed its strategic pivot from a research and development-driven company to a commercially focused biotechnology solutions provider underpinned by our protein production platforms,” said Joe Hazelton, President and Chief Operating Officer of Dyadic
- Dyadic Announces Top-Line Results from its Successful Phase 1 Clinical . . .
Dyadic International, Inc is a global biotechnology company focused on building innovative microbial platforms to address the growing demand for global protein bioproduction and unmet clinical needs for effective, affordable, and accessible biopharmaceutical products for human and animal health
- Dyadic Receives $3 Million Grant to Develop Cost-Effective Monoclonal . . .
Dyadic International, Inc , is a biotechnology company focused on the efficient large-scale manufacture of proteins for use in human and animal vaccines and therapeutics and for use in non-pharmaceutical applications including food, nutrition, and wellness
|
|
|